CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues

American Journal of Pathology

Volumn 149, Issue 2, 1996, Pages 469-481

  Gruss, Hans Jürgen ^a,b,c   Pinto, Antonio ^d   Gloghini, Annunziata ^e   Wehnes, Engelbert ^a,b   Wright, Barbara ^f   Boiani, Norman ^f   Aldinucci, Donatella ^d   Gattei, Valter ^d   Zagonel, Vittorina ^h   Smith, Craig A ^f   Kadin, Marshall E ^g   Von Schilling, Christoph ^a,b   Goodwin, Raymond G ^f   Herrmann, Friedhelm ^a,b,c   Carbone, Antonino ^e  

^a HUMBOLDT UNIVERSITY   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d Department of Medical Oncology   (Italy)

^e CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^f AMGEN INC   (United States)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN;

ARTICLE; CARCINOGENESIS; HODGKIN DISEASE; HUMAN; HUMAN CELL; MITOGENESIS; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, SURFACE; CD30 LIGAND; CELL COUNT; FLOW CYTOMETRY; GRANULOCYTES; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOID TISSUE; MEMBRANE GLYCOPROTEINS; RECOMBINANT PROTEINS; REED-STERNBERG CELLS;

EID: 9344260220     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Schwab U, Stein H, Gerdes J, Lemke H, Kirchner H, Schaadt M, Diehl V: Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982, 299:65-67
2. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985, 66: 848-854
3. Schwarting R, Gerdes J, Dürkop H, Falini B, Pileri S, Stein H: BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 1989, 74:1678-1689
4. Stein H, Gerdes J, Schwab U, Lemke H, Mason D, Ziegler A, Schienle W, Diehl V: Identification of Hodgkin and Sternberg-Reed cells as a unique cell type derived from a newly-detected small-cell population, Int J Cancer 1982, 30:445-449
5. Andreesen R, Osterholz J, Löhr GW, Bross KJ: A Hodgkin cell-specific antigen is expressed on a subset of auto- and alloactivated T (helper) lymphoblasts Blood 1984, 63:1299-1302
6. Hecht TT, Longo DL, Cossman J, Bolen JB, Hsu SM, Israel M, Fisher RI: Production and characterization of a monoclonal antibody that binds Reed-Sternberg cells. J Immunol 1985, 134:4231-4236
7. Dürkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H: Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 1992, 68. 421-427
8. Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994, 75:959-962
9. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi J-P, van Kooten C, Liu YJ, Rousset F, Saeland S: The CD40 antigen and its ligand. Annu Rev Immunol 1994, 12:881-922
10. Armitage RJ: Tumor necrosis factor receptor superfamily members and their ligands. Curr Opin Immunol 1994, 6:407-413
11. Smith CA, Gruss HJ, Davis T, Anderson D, Farrah T, Baker E, Sutherland GR, Brannan CI, Copeland NG, Jenkins NA, Grabstein KH, Gliniak B, McAlister IB, Fanslow W, Alderson M, Falk B, Gimpel S, Gillis S, Din WS, Goodwin RG, Armitage RJ: CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 1993, 73:1349-1360
12. Gruss HJ, Boiani N, Williams DE, Armitage RJ, Smith CA, Goodwin RG: Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 1994, 83:2045-2056
13. Gruss H-J, DaSilva N, Hu Z-B, Uphoff CC, Goodwin RG, Drexler HG: Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines. Leukemia 1994, 8:2083-2094
14. Gruss H-J, Herrmann F: CD30 ligand, a member of the TNF ligand superfamily, with growth, and activation control for CD30+ lymphoid, and lymphoma cells. Leuk Lymphoma 1996, 20:397-409
15. Gruss H-J, Hirschstein D, Alderson MR, Herrmann F, Armitage RJ: Regulation of CD30 ligand expression on peripheral blood T cells: possible functional involvement in T-T cell interaction. J Immunol 1996 (in press)
16. Gruss H-J, Ulrich D, Braddy S, Armitage RJ, Dower SK: Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells. Eur J Immunol 1995, 25:2083-2089
17. Kadin ME: Pathology of Hodgkin's disease. Curr Opin Oncol 1994, 6:456-463
18. Gruss H-J, Herrmann F, Drexler HG: Hodgkin's disease: a cytokine producing tumor. Crit Rev Oncogenesis 1994, 5:473-538
19. Armitage RJ, Beckmann MP, Idzerda RL, Alpert A, Fanslow WC: Regulation of interleukin 4 receptors on human T cells, Int Immunol 1990, 2:1039-1045
20. Brattig NW, Medina-De la Garza CE, Tischendorf FW: Comparative study of eosinophil purification on nycodenz, metrizamide, and percoll density gradients. Eur J Haematol 1987, 39:148-153
21. McMahan CJ, Slack JL, Mosley B, Cosman D, Lupton SD, Brunton LL, Grubin CE, Wignall JM, Jenkins NA, Brannan CI, Copeland NG, Huebner K, Croce CM, Cannizzarro LA, Benjamin D, Dower SK, Spriggs MK, Sims JE: A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J 1991, 10:2821-2832
22. Gruss H-J, Hirschstein D, Wright B, Ulrich D, Caligiuri MA, Strockbine L, Armitage RJ, Dower SK: Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease. Blood 1994, 84:2305-2314
23. Carbone A, Gloghini A, Gattei V, Aldinucci D, Degan M, Paoli PD, Zagonel V, Pinto A: Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Blood 1995, 85:780-789
24. Carbone A, Gloghini A, Gruss H-J, Pinto A: CD40 ligand is constitutively expressed in a subset of T-cell lymphomas and on the microenvironmental reactive T-cells of follicular lymphomas and Hodgkin's disease Am J Pathol 1995, 147:912-922
25. Fanslow WC, Anderson D, Grabstein KH, Clark EA, Cosman D, Armitage RJ: Soluble forms of CD40 inhibit biologic responses of human B cells. J Immunol 1992, 149:655-660
26. +) lymphomas. Virchows Arch A Pathol Anat Histopathol 1992, 420: 527-532
27. + anaplastic large cell lymphomas. Blood 1994, 83:785-792
28. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, Macdonald S, Pulford KAF, Stein H, Mason DY: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984, 32:219-229
29. Hsu SM, Raine L, Fanger H: The use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981, 29:577-580
30. Gauchat J-F, Henchoz S, Mazzei G, Aubry J-P, Brunner T, Blasey H, Life P, Talabot D, Flores-Romo L, Thompson J, Kishi K, Butterfield J, Dahinden C, Bonnefoy J-Y: Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 1993, 365:340-343
31. Drexler HG: Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. Biopsy material. Leuk Lymphoma 1992, 8:283-313
32. + malignant lymphomas. Crit Rev Oncogenesis 1993, 4:191-239
33. Falini B, Pileri S, Pizzolo G, Dürkop H, Flenghi L, Stirpe F, Martelli MF, Stein H: CD30 (Ki-1)+ molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 1995, 85:1-14
34. Gruss H-J, Dower SK: TNF ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 1995, 85:3378-3404
35. + T cells. J Immunol 1993, 151:2380-2389
36. Alzona M, Jäck H-M, Fisher R, Ellis TM: CD30 defines a subset of activated human T cells that produce IFN-γ and IL-5 and exhibit enhanced B cell helper activity. J Immunol 1994, 153:2861-2867
37. + T cells. J Immunol 1995, 154:9-16
38. + T cell clones in human immunodeficiency virus infection. J Exp Med 1994, 180:2407-2411
39. + T cells producing Th2-type cytokines, FASEB J 1995, 9:81-86
40. Poppema S: The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease. Am J Pathol 1989, 135:351-357
41. Lane P, Traunecker A, Hubele S, Inui S, Lanzavecchia A, Gray D: Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol 1992, 22:2573-2578
42. Spriggs MK, Armitage RJ, Strockbine L, Clifford KN, Macduff BM, Sato TA, Maliszewski CR, Fanslow WC: Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med 1992, 176:1543-1550
43. Sanders ME, Makgoba MW, Sussman EH, Luce GEG, Cossman J, Shaw S: Molecular pathways of adhesion in spontaneous resetting of T-lymphocytes to the Hodgkin's cell line L428. Cancer Res 1988, 48:37-40
44. Drexler HG: Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines. Leuk Lymphoma 1993, 9:1-24
45. Delabie J, Ceuppens JL, Vandenberghe P, de Boer M, Coorevits L, De Wolf-Peeters C: The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines. Blood 1993, 82:2845-2852
46. Munro JM, Freedman AS, Aster JC, Gribben JG, Lee NC, Rhynhart KK, Banchereau J, Nadler LM: In vivo expression of the B7 costimulatory molecule by subsets of antigen-presenting cells and malignant cells of Hodgkin's disease. Blood 1994, 83:793-798
47. Springer TA: Adhesion receptors of the immune system. Nature 1990, 346:425-434
48. Schwartz RH: Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992, 71:1065-1068
49. Ruco LP, Pomponi D, Pigott R, Gearing AJ, Baiocchini A, Baroni CD: Expression and cell distribution of the intercellular adhesion molecule, vascular cell adhesion molecule, endothelial leukocyte adhesion molecule, and endothelial cell adhesion molecule (CD31) in reactive human lymph nodes and in Hodgkin's disease. Am J Pathol 1992, 140:1337-1344